Montelukast versus inhaled corticosteroids as monotherapy for prevention of asthma: which one is best?

Allergologia et Immunopathologia

Volumn 37, Issue 1, 2009, Pages 26-30

  Miceli Sopo, S ^a   Onesimo, R ^a   Radzik, D ^b   Scala, G ^c   Cardinale, F ^d  

^a CATHOLIC UNIVERSITY   (Italy)

^b San Giacomo Hospital   (Italy)

^c Loreto Crispi Hospital   (Italy)

^d UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FORMOTEROL; MONTELUKAST; PLACEBO; SALMETEROL; TRIAMCINOLONE;

ARTICLE; ASTHMA; CHILDHOOD DISEASE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; HUMAN; META ANALYSIS; MONOTHERAPY; MORNING DOSAGE; SYSTEMATIC REVIEW; WHEEZING;

ACETATES; ADOLESCENT; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; HUMANS; QUINOLINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 62249199773     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/S0301-0546(09)70248-4     Document Type: Article

References (16)

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NIH Pub. No 02-3659, January 1995. Updated 2006. [cited 2006 Oct 24]. Available from: www.ginasthma. com.
2. British Thoracic Society Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. Thorax 63 Suppl 4 (2008) iv1-iv121
3. Bacharier L.B., Boner A., Carlsen K.H., Eigenmann P.A., Frischer T., Gotz M., et al., The European Pediatric Asthma Group. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 63 (2008) 5-34
4. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
5. Stelmach I., Jerzynska J., and Kuna P. A randomized, double-blind trial of the effect of glucocorticoid, antileukotriene and beta-agonist treatment on IL-10 serum levels in children with asthma. Clin Exp Allergy 32 (2002) 264-269
6. Stelmach I., Bobrowska-Korzeniowska M., Majak P., Stelmach W., and Kuna P. The effect of MLK and different doses of budesonide on IgE serum levels and clinical parameters in children with newly diagnosed asthma. Pulm Pharmacol Ther 18 (2005) 374-380
7. Ostrom N.K., Decotiis B.A., Lincourt W.R., Edwards L.D., Hanson K.M., Carranza Rosenzweig J.R., et al. Comparative efficacy and safety of low-dose FP propionate and MLK in children with persistent asthma. J Pediatr 147 (2005) 213-220
8. Garcia Garcia M.L., Wahn U., Gilles L., Swern A., Tozzi C.A., and Polos P. Montelukast compared with fl uticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 116 (2005) 360-369
9. Zeiger R.S., Szefl er S.J., Phillips B.R., Schatz M., Martinez F.D., Chinchilli V.M., et al. Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Response profiles to FP and MLK in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 117 (2006) 45-52
10. Sorkness C.A., Lemanske Jr. R.F., Mauger D.T., Boehmer S.J., Chinchilli V.M., Martinez F.D., et al. Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 119 (2007) 64-72
11. Kumar V, Ramesh P, Lodha R, Pandey RM, Kabra SK. MLK vs. Inhaled Low-Dose Budesonide as Monotherapy in the Treatment of Mild Persistent Asthma: A Randomized Double Blind Controlled Trial. J Trop Pediatr. 2007;53:325-30.
12. Kooi E.M.W., Schokker S., Boezen H.M., de Vries T.W., Vaessen-Verberne A., van der Molen T., et al. Fluticasone or montelukast for preschool children with asthma-like symptoms: Randomized controlled trial. Pulm Pharmacol Ther (2008) doi:10.1016/j.pupt.2008.06.004
13. Szefler S.J., Baker J.W., Uryniak T., Goldman M., and Silkoff P.E. Comparative study of budesonide inhalation suspension and MLK in young children with mild persistent asthma. J Allergy Clin Immunol 120 (2007) 1043-1050
14. Peters S.P., Anthonisen N., Castro M., Holbrook J.T., Irvin C.G., Smith L.J., et al., For American Lung Association Asthma Clinical Research Centers. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 356 (2007) 2027-2039
15. Pedersen S., Agertoft L., Williams-Herman D., Kuznetsova O., Reiss T.F., Knorr B., et al. Placebo-Controlled Study of MLK and Budesonide on Short-Term Growth in Prepubertal Asthmatic Children. Pediatric Pulmonology 42 (2007) 838-843
16. Turpeinen M.T., Nikander K., Pelkonen A., Syvänen P., Sorva R., Raitio H., et al. Daily versus As-Needed Inhaled Corticosteroid for Mild Persistent Asthma - The Helsinki Early Intervention Childhood Asthma Study. Arch Dis Child 93 (2008) 654-659